WO2011017107A3 - Administration virale aidée par microbulle - Google Patents

Administration virale aidée par microbulle Download PDF

Info

Publication number
WO2011017107A3
WO2011017107A3 PCT/US2010/043403 US2010043403W WO2011017107A3 WO 2011017107 A3 WO2011017107 A3 WO 2011017107A3 US 2010043403 W US2010043403 W US 2010043403W WO 2011017107 A3 WO2011017107 A3 WO 2011017107A3
Authority
WO
WIPO (PCT)
Prior art keywords
virus
microbubble
suspension
microbubbles
viral delivery
Prior art date
Application number
PCT/US2010/043403
Other languages
English (en)
Other versions
WO2011017107A2 (fr
Inventor
Paul B. Fischer
Devanand Sarkar
Rupesh Dash
Belal Mohammed Azab
Xiang-Yang Wang
Pier Paolo Claudio
Original Assignee
Virginia Commonwealth University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virginia Commonwealth University filed Critical Virginia Commonwealth University
Priority to US13/386,165 priority Critical patent/US20120195935A1/en
Publication of WO2011017107A2 publication Critical patent/WO2011017107A2/fr
Publication of WO2011017107A3 publication Critical patent/WO2011017107A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/761—Adenovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10345—Special targeting system for viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10371—Demonstrated in vivo effect
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention porte sur l'administration de virus aidée par microbulle. En particulier, l'invention porte sur des procédés pour cibler un virus dans des cellules cancéreuses dans un animal immunocompétent, par l'administration d'un virus à réplication sélective à l'animal immunocompétent et la rupture des microbulles dans un emplacement de l'animal comprenant des cellules cancéreuses. Le virus est englobé dans une suspension de microbulles et la surface de la suspension ne comprend aucun virus. L'invention porte également sur une suspension de microbulles comprenant un virus à réplication sélective qui est englobé dans une suspension de microbulles, qui ne comprend aucun virus sur la surface de la suspension.
PCT/US2010/043403 2009-07-27 2010-07-27 Administration virale aidée par microbulle WO2011017107A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/386,165 US20120195935A1 (en) 2009-07-27 2010-07-27 Microbubble assisted viral delivery

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22872109P 2009-07-27 2009-07-27
US61/228,721 2009-07-27

Publications (2)

Publication Number Publication Date
WO2011017107A2 WO2011017107A2 (fr) 2011-02-10
WO2011017107A3 true WO2011017107A3 (fr) 2011-06-16

Family

ID=43544861

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/043403 WO2011017107A2 (fr) 2009-07-27 2010-07-27 Administration virale aidée par microbulle

Country Status (2)

Country Link
US (1) US20120195935A1 (fr)
WO (1) WO2011017107A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110585127B (zh) * 2019-07-15 2022-03-08 三峡大学 靶向pd-l1微泡的制备方法及在制备抑制宫颈癌的药物上的应用

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2914136T3 (pl) 2012-11-02 2021-11-29 N.V. Nutricia Połączenie synbiotyków do poprawy czynności mózgu
US10314870B2 (en) 2012-12-10 2019-06-11 Virginia Commonwealth University Tropism modified cancer terminator virus (Ad.5/3 CTV;AD.5/3-CTV-M7)
US10166300B2 (en) 2013-06-04 2019-01-01 Virginia Commonwealth University Tripartite cancer theranostic nucleic acid constructs

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040151702A1 (en) * 2001-04-20 2004-08-05 Rainer Marksteiner Production and use of a suspension composition comprising an ultrasound contrast medium
US20080063604A1 (en) * 2006-09-12 2008-03-13 Temple University - Of The Commonwealth System Of Higher Education Method and composition for the site-selective gene delivery using viruses
US20080145937A1 (en) * 2006-09-22 2008-06-19 Baylor Research Institute In Vivo Transformation of Pancreatic Acinar Cells into Insulin-Producing Cells

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040151702A1 (en) * 2001-04-20 2004-08-05 Rainer Marksteiner Production and use of a suspension composition comprising an ultrasound contrast medium
US20080063604A1 (en) * 2006-09-12 2008-03-13 Temple University - Of The Commonwealth System Of Higher Education Method and composition for the site-selective gene delivery using viruses
US20080145937A1 (en) * 2006-09-22 2008-06-19 Baylor Research Institute In Vivo Transformation of Pancreatic Acinar Cells into Insulin-Producing Cells

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110585127B (zh) * 2019-07-15 2022-03-08 三峡大学 靶向pd-l1微泡的制备方法及在制备抑制宫颈癌的药物上的应用

Also Published As

Publication number Publication date
WO2011017107A2 (fr) 2011-02-10
US20120195935A1 (en) 2012-08-02

Similar Documents

Publication Publication Date Title
USD704807S1 (en) Waterspout
WO2012009406A3 (fr) Particules d'or et leurs procédés de fabrication et d'utilisation dans le traitement du cancer
WO2012106713A3 (fr) Conjugués de nanoparticule ciblés
HRP20182194T1 (hr) Onkolitički herpes simpleks virus i njegova terapeutska uporaba
WO2013078199A3 (fr) Méthodes pour une administration in vivo améliorée d'arn synthétiques modifiés
UA108598C2 (xx) Високоефективні кон'югати та гідрофільні зшиваючі агенти (лінкери)
TW200744618A (en) Use of local immune suppression to enhance oncolytic viral therapy
WO2007038249A3 (fr) Concentration par ultrasons de particules de support
MX2012011222A (es) Compuestos y composiciones farmaceuticas para el tratamiento de infecciones virales.
SG178885A1 (en) Generation of ctl lines with specificity against multiple tumor antigens or multiple viruses
WO2012019168A3 (fr) Acides nucléiques modifiés et leurs procédés d'utilisation
WO2011017107A3 (fr) Administration virale aidée par microbulle
WO2009118658A3 (fr) Liposomes ciblant le réticulum endoplasmique
WO2011036107A3 (fr) Système de portage muni d'un gilet pare-balles
EP2486137A4 (fr) Réplication de vecteurs viraux pour thérapie génique
WO2011072247A8 (fr) Facteurs de restriction pathogènes
MX2011002506A (es) Aglutinantes basados en estireno-butadieno y metodos para preparar y usar los mismos.
WO2008093166A3 (fr) Compositions associées à la sialoadhésine et procédés correspondants
IN2012DN03209A (fr)
WO2010143969A3 (fr) Particules d'administration de médicament présentant une sensibilité acoustique comprenant de la phosphatidyléthanolamine formant des structures non lamellaires
HK1216544A1 (zh) 病毒載體納米膠囊靶向基因治療及其製備
WO2011039646A3 (fr) Ciblage de particules d'administration de gène de papillomavirus
WO2011127019A3 (fr) Méthodes de traitement d'une infection respiratoire d'origine virale
WO2012040331A3 (fr) Nanoparticules multicouches
MX339014B (es) Modulacion de presion intersticial y suministro y distribucion viral oncolitica.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10806890

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 13386165

Country of ref document: US

122 Ep: pct application non-entry in european phase

Ref document number: 10806890

Country of ref document: EP

Kind code of ref document: A2